MENU
CATX
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Perspective Therapeutics (CATX) Ownership - Who owns Perspective Therapeutics?
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
2401 Elliott Avenue
Phone
+1 206 676-0900
Employees
119
Web
https://www.perspectivetherapeutics.com
Details
Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
751.25M
P/E Ratio
N/A
Total Cash
9.24M
Projected Growth
N/A
Total Debt
2.55M
Revenue
N/A
Risk (Beta)
2.50
Dividend Yield
N/A
Total Cash/Share
0.02
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CATX
Capitalization
751M
P/E Ratio
N/A
Risk (Beta)
2.50
Dividend Yield
N/A
Total Cash
9.24M
Total Cash/Share
0.02
Total Debt
2.55M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
75.2M
P/B Ratio
9.99
Cash Flow
N/A
Earnings
-0.17
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
282K
Current Ratio
1.07
Current Revenue Per Employee
20978.02
Dividends Per Share - Security
N/A
EBITDA
-39.08M
Float
N/A
Float - Current
N/A
Gross Income Margin
38.66
Revenue To Assets
-59.63
Shares Held By Institutions
29.2M
Shares Outstanding - Current
587M
Total Liabilities
22.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-26.959
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a producer of therapeutic radioactive isotopes
Industry MedicalSpecialties
Profile
Fundamentals
Details
Industry
Biotechnology
Address
2401 Elliott Avenue
Phone
+1 206 676-0900
Employees
119
Web
https://www.perspectivetherapeutics.com